p-fin4 , CAS No.2883747-74-6

CAS: 2883747-74-6 Cat. No.: P1437128 Fórmula: C39H53N8O18P Peso molecular: 952.85
Disponible para pedir
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Talla
USA
Alemania (EU)*
Precio
Cantidad
1mg
P1437128-1mg
Fabricado bajo pedido · 8–12 semanas
Enter a quantity for the sizes you want to add.

Descripción general

p-fin4 is a peptide inhibitor of STEP Phosphatase-GluA2 AMPA receptor interaction with a Ki of 0.4 μM. p-fin4 restores the memory deficits and displays anxiolytic and antidepressant effects in a scopolamine-treated rat model. p-fin4 is a promising lead compound for novel cognitive enhancers and/or behavioral modulators.

Especificaciones

Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Nombres e identificadores
Peso molecular
952.85

Datos avanzados

Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Application Protocols

No tested application protocols are provided for this specific product.

General workflow suggestions for small-molecule screening (research use only):

  • Stock preparation: Dissolve in DMSO to 10–50 mM; vortex and, if needed, sonicate. Filter (0.22 μm PTFE) or centrifuge prior to plating.
  • Plating: Use low-retention tips/plates; avoid prolonged exposure to air/light if the compound is light/air sensitive (status unknown—handle cautiously).
  • Assay dilution: Target final DMSO ≤0.5% v/v in wells; include solvent-matched vehicle controls.
  • Storage of working plates: Seal and store at −20°C to −80°C (assay-dependent); minimize freeze–thaw cycles.
  • Analytics: Verify concentration by UV (if chromophore present) or LC–MS quantitative methods with internal standards.

These are general, non-item-specific recommendations; adapt to your assay system and consult the SDS and CoA for any constraints unique to this material.

Biological Roles

Item-specific biological function, targets, and pathways for p-fin4 are not provided.

  • Mechanism of action, target class, and pathway annotation: Not specified for this item; refer to CoA/Spec Sheet or primary literature if available for this CAS.
  • Bioactivity status (agonist/antagonist/inhibitor, etc.): Not specified for this item; refer to CoA/Spec Sheet.

General considerations for small-molecule library members:

  • Perform broad cytotoxicity and off-target liability screening (e.g., counterscreens for redox cycling, detergent-like effects, assay fluorescence quenching).
  • Determine physicochemical liabilities that influence biological performance (solubility, permeability, stability in media, plasma protein binding) using standard in vitro assays.
  • Evaluate metabolic stability and reactive metabolite risk in microsomes/S9 only within research contexts.

Compliance note:

  • For research use only. Not for diagnostic, therapeutic, or clinical use. No medical or clinical claims are made or implied for this product.

Documentation:

  • If biological roles are later established, capture them in an internal data sheet with assay conditions, target provenance, and QC traceability (lot-to-lot comparison).
Buffer Applications

This product is a small-molecule library member and is not itself a buffering agent. No pKa or acid/base information is provided to enable formulation of a defined buffer system.

  • Buffer use: Not typically applicable to this item. If dissolved for bioassays, it is usually in non-buffer roles (e.g., as a solute in DMSO stocks diluted into assay buffers).

Practical notes (general):

  • When diluting DMSO stocks into buffers (e.g., PBS, HEPES, Tris), add slowly with mixing to avoid local supersaturation and precipitation.
  • Maintain constant ionic strength and pH across control and compound wells to avoid confounding effects.
  • If the compound is ionic (unknown here), buffer selection and pH may affect solubility and potency; determine pH–solubility profiles experimentally.
Green Alternatives

Green chemistry considerations depend on solvent and process choices, which in turn depend on the compound’s structure and solubility—both not specified here. The following guidance is general for handling small-molecule stocks and assay preparations.

Greener handling practices (general):

  • Prefer aqueous buffers with minimal DMSO where feasible; cap final DMSO ≤0.1–0.5% in biological assays to reduce solvent burden.
  • Use 2-methyltetrahydrofuran (2-MeTHF), CPME, or EtOAc instead of chlorinated solvents for any workup or formulation steps, if compatible.
  • Minimize DMF/NMP usage due to reproductive toxicity profiles; substitute with safer alternatives (e.g., Cyrene, propylene carbonate) when solubility allows.

Small comparison (general):

  • DMSO: High solvency, low volatility; waste reduction benefit but potential stability issues.
  • 2-MeTHF/CPME: Bio-based or lower-impact ethers for extractions; peroxide testing required on prolonged storage.
  • EtOAc/IPA: Favorable EHS profile for rinses and crystallizations versus chlorinated solvents.

Operational tips:

  • Right-size stocks (aliquot at high concentration) to reduce repeat dissolutions and solvent use.
  • Employ microscale assays and plate-based workflows to minimize solvent volumes.

Item-specific greener substitutions cannot be proposed without structural and functional information; consult the CoA and pilot tests.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation use is specified for this item.

  • Regulatory grade/monographs: Not specified for this item; refer to CoA/Spec Sheet.
  • Intended use statement: For research use only. Not for human or veterinary use, drug, or household use.

General R&D context (non-clinical):

  • Compounds in screening libraries may be utilized in pre-formulation research (solubility screening, stability studies) strictly within non-clinical settings.
  • Any development beyond research discovery requires comprehensive quality, safety, and regulatory assessments not covered by this listing.

Important: No therapeutic claims are made. This product is not an API, nor is it qualified as a GMP-grade material.

Physical Properties

Item-specific physicochemical specifications are not provided.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • logP/logD, pKa: Not specified for this item; refer to CoA/Spec Sheet.

General laboratory guidance (literature/general):

  • For uncharacterized small molecules used in screening, preliminary solubility testing is commonly performed in DMSO (10–50 mg/mL), DMF, ethanol, and aqueous buffer with co-solvent.
  • If solid, assess polymorph/solvate state by DSC/TGA and PXRD when needed for reproducibility.
  • Determine UV-Vis profile (200–400 nm) and LC–MS response to support analytical method development; do not treat these as specifications unless verified on the CoA.

Important note:

  • Do not treat any generalized values as specifications. For authoritative, lot-specific numbers (e.g., MP, HPLC purity, water content), consult the item’s CoA/Spec Sheet.
Quality and Grades

Item-specific grade/purity information is not provided in the Product Data.

  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Guidance on interpreting grades (general):

  • Research grade: Suitable for discovery research; may not meet pharmacopeial monographs.
  • Screening/Library grade: Emphasis on identity confirmation (LC–MS/NMR) and typical purity ≥90–95% by HPLC, unless otherwise noted on the CoA. UV cutoffs/trace metal levels are generally not controlled unless specified.
  • HPLC/LC–MS suitability: When stated, implies low non-volatile residues and defined purity determination method; verify on CoA.

Recommended quality controls upon receipt (general best practice):

  • Identity: LC–MS and 1H NMR spot check.
  • Purity: Analytical HPLC/UPLC area% at ≥2 wavelengths.
  • Residual solvents/water: Karl Fischer and GC headspace if formulation sensitivity is anticipated.

Stabilizers and inhibitors:

  • Stabilizer content for this item: Not specified for this item; refer to CoA/Spec Sheet.
  • If stabilizers are present, they may affect bioassays or reactions; account for them in controls.

Note: Do not infer numeric specifications. Rely on the lot-specific CoA for acceptance criteria.

Reaction and Applications

This item is cataloged as a small-molecule/library compound for research screening rather than as a synthetic reagent. No manufacturer application notes are provided beyond research use.

Typical research uses (general):

  • Tool compound screening in biochemical or cell-based assays (target-agnostic or targeted), SAR exploration, and phenotypic profiling.
  • Analytical reference standard development: method qualification in LC–MS or HPLC where appropriate.

If repurposed as a synthetic building block (only if structure supports it):

  • Without structural information, no specific reactivity guidance can be offered. Confirm functional groups prior to any synthetic use.

Best practices:

  • Establish an analytical method (UPLC–UV/HRMS) to monitor stability under storage/assay conditions.
  • Conduct preliminary interference testing (e.g., redox cycling, assay fluorescence/absorbance overlap) before committing to screening campaigns.

Note: As no structural or reactivity data are provided, avoid assuming compatibility with moisture/air-sensitive or metal-catalyzed transformations until the structure is verified.

Reaction Conditions

Item-specific reaction conditions are not applicable because this product is positioned as a screening/library compound and no functional groups are disclosed.

General laboratory guidance if used in transformations (only after structure confirmation):

  • Solvent: Choose based on functionality (e.g., polar aprotic for cross-coupling or amide formations; alcohols/ethers for neutral substitutions).
  • Temperature: Start with ambient to 80°C depending on reaction class; monitor by TLC/UPLC–MS.
  • Catalysts/bases: Select per transformation (e.g., Pd(0)/phosphine ligands for C–C/C–N couplings; carbodiimide or HOAt/HOBt-free alternatives for amidations).
  • Atmosphere: Use inert gas (N2/Ar) for air- or moisture-sensitive steps.

Expected yields, times, and quench/workup are inherently structure-dependent and cannot be specified without the molecular identity. Consult primary literature once the structure is defined.

Safety and Handling

Safety information for this specific item is not provided in the Product Data. Always consult the SDS prior to use.

  • GHS classification: Not specified for this item; refer to SDS.
  • Signal word / H-statements / Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (good practice):

  • Use in a chemical fume hood. Wear appropriate PPE: lab coat, safety glasses, and chemically resistant gloves.
  • Avoid inhalation of dust/aerosols and contact with skin/eyes. Wash thoroughly after handling.
  • Storage incompatibilities: Until structure is known, segregate from strong oxidizers, strong acids/bases, and moisture-sensitive reagents as a precaution.
  • Thermal sensitivity: Unknown; store as directed at −20°C and protect from light until more information is available.

First-aid overview (general):

  • Inhalation: Move to fresh air; seek medical attention if symptoms persist.
  • Skin/eye contact: Rinse with water for at least 15 minutes; remove contaminated clothing; seek medical attention if irritation persists.
  • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.

Waste disposal:

  • Collect as organic chemical waste; dispose in accordance with institutional and local regulations.

Authoritative source:

  • Defer to the current SDS for definitive hazard classification and response guidance for this specific item.
Solvent Selection

Because no structural or solubility data are provided, solvent choices should be established empirically for this item.

Practical approach (general guidance):

  • Primary stock solution screening: DMSO (10–50 mg/mL) is the standard for small-molecule libraries due to broad solvency and assay compatibility at ≤0.5% v/v final.
  • Secondary organic solvents: DMF, NMP, ethanol, methanol, acetonitrile. Begin at 5–10 mg/mL and adjust.
  • Aqueous work: Prepare concentrated DMSO stock and dilute into buffer with vortexing/sonication; maintain final DMSO ≤0.1–0.5% where possible.
  • Surfactant-assisted dissolution (if needed): 0.01–0.05% Tween-80 or Pluronic F-127 can improve dispersion in biological assays (validate for assay interference).

Small comparison (general, literature):

  • DMSO: Highest solvency; widely used in HTS. Potential for compound oxidation over long storage; store aliquots at −20°C.
  • DMF/NMP: Strong solvents; higher cytotoxicity risk; limit residual content in bioassays.
  • Ethanol/ACN: Volatile, lower solvency breadth; suitable for analytical dilutions.

Tips:

  • Filter or centrifuge to remove microprecipitates before sensitive assays.
  • Verify solubility at intended assay temperature, ionic strength, and pH; many heteroaromatics exhibit pH-dependent solubility.
  • Record exact solvent lot and preparation to aid reproducibility.
Storage and Reconstitution

Item-specific conditions provided:

  • Storage: Store at −20°C (from Product Data).
  • Shipping: Shipped in ice chest + ice pads (from Product Data).

Additional best practices (general):

  • Protect from light and moisture until more information is available on stability. Keep container tightly closed under an inert headspace if feasible.
  • Upon first opening, equilibrate to room temperature in a desiccator before unsealing to minimize condensation.

Reconstitution guidance (general for small molecules):

  • Prepare concentrated stock in DMSO (e.g., 10–50 mM) unless CoA indicates otherwise. Mix thoroughly; gentle warming (≤40°C) or brief sonication can aid dissolution.
  • If aqueous stocks are required, consider co-solvent strategies (DMSO 1–10% v/v) and verify stability/solubility at target pH and ionic strength.
  • Aliquot stocks into single-use volumes; avoid repeated freeze–thaw cycles. Typical storage: −20°C for weeks to months; −80°C for long-term archival.
  • Label aliquots with concentration, solvent, date, and lot.

Specifications not provided:

  • Appearance, purity, water content, stabilizers, and exact solubility: Not specified for this item; refer to CoA/Spec Sheet.

Always consult the lot-specific CoA and SDS for authoritative guidance on storage limits, stability, and handling.

Structure and Identity

Brief overview: This item is listed as a small-molecule library member; detailed structural identifiers are not provided in the Product Data.

  • Product name: p-fin4 (catalog reference name)
  • CAS: 2883747-74-6
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChI / InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • Synonyms: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

  • Functional groups, ring systems, stereochemistry, and heteroatom content are not provided in the current listing and should be confirmed from the CoA/SDS or primary reference.
  • For cheminformatics tracking and registration, assign an internal identifier (SKU: P1437128) and update once a definitive structure file (SDF/MOL) is obtained.

Data provenance:

  • All item-specific structural fields above are reported exactly as provided in Product Data. Where absent, we explicitly state that they are not specified.
Synthetic Utility

No structural or functional group information is provided, so item-specific synthetic reactivity cannot be described.

General guidance if structure becomes available:

  • Identify key functional groups (e.g., aryl halide, heteroaryl, amide, nitrile, alcohol) to map onto canonical transformations (Suzuki–Miyaura, Buchwald–Hartwig, amide coupling, reductions/oxidations).
  • Evaluate protecting group strategy if polyfunctional: orthogonal handles facilitate diversity-oriented synthesis when generating analogs.
  • Develop LC–MS methods for tracking conversions and impurity profiles; define triggers for purification (e.g., ≥95% area by UPLC).

Retrosynthetic considerations (general):

  • Break down to commercially available building blocks with robust coupling chemistry.
  • Consider scalable convergent steps and late-stage diversification handles to accelerate SAR.

Note: Until the exact structure is confirmed (SMILES/InChI), treat this product primarily as a screening compound rather than as a synthetic intermediate.

Target Specificity

Target information is not provided for this item.

  • Target/Pathway, binding mode, selectivity panel, KD/IC50 values: Not specified for this item; refer to CoA/Spec Sheet or internal assay data if available.

Guidance (general):

  • If used as a probe, perform orthogonal assays (biochemical, biophysical, and cellular) to confirm on-target engagement and rule out assay artifacts.
  • Apply counter-screens against common nuisance mechanisms (aggregate formation, redox cycling, chelation of assay metals, pan-assay interference).

Preguntas frecuentes

How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 2883747-74-6, the molecular formula is C39H53N8O18P, and the molecular weight is 952.85 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.